Abstract
The characterization of cancer through gene expression quantification data analysis is a powerful and widely used approach in cancer research. This paper describes two experiments that demonstrate its potential in identifying differentially expressed genes (DEGs) and accurately predicting cancer subtypes. To achieve this, RNA-seq data was obtained from TCGA database and subsequently preprocessed and analyzed using the KnowSeq package from Bioconductor. In the first experiment, the study focuses on identifying DEGs in healthy, cervical cancerous, and uterine corpus cancerous tissues. The kNN classifier was employed to evaluate the utility of these genes in predicting a sample belonging to one of these three classes. A gene signature consisting of only three genes produced remarkable results on a 5-fold cross-validation assessment process, with overall test accuracy and F1 values of 99.33% and 96.73%, respectively. The paper provides ontological enrichment, associated diseases, and pathways of the gene signature to shed light on the molecular mechanisms involved in both cancers. The second experiment extends the work by classifying cervical cancer samples into their two most common histological types: adenocarcinoma and squamous cell carcinoma. By using a single gene, the study was able to achieve 100% of test accuracy in a 5-fold cross-validation process. Additionally, the classification of an adenosquamous sample into one of these two categories based on the number of genes used was also examined. Overall, these experiments demonstrate the potential of these techniques to improve cancer diagnosis and treatment. Moreover, the study provides valuable insights into the underlying molecular mechanisms of cervix and uterine corpus cancers, laying the groundwork for further research in this field.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American society of clinical oncology. Uterine Cancer - Introduction – cancer.net. https://www.cancer.net/cancer-types/uterine-cancer/introduction. Approved by the Cancer. Net Editorial Board, 02/2022. Accessed 3 Feb 2023
Cervical cancer – who.int. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed 25 Mar 2023
Genecards human gene database. https://www.genecards.org/. Accessed 4 Mar 2023
KnowSeq – bioconductor.org. https://www.bioconductor.org/packages/release/bioc/html/KnowSeq.html. Accessed 20 Feb 2023
Open Targets Platform – platform.opentargets.org. https://platform.opentargets.org/. Accessed 4 Mar 2023
VWCE von Willebrand factor C and EGF domains [Homo sapiens (human)] - Gene - NCBI – ncbi.nlm.nih.gov. https://www.ncbi.nlm.nih.gov/gene/220001. Accessed 3 Mar 2023
Balcacer, P., Shergill, A., Litkouhi, B.: MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfalls. Abdom. Radiol. 44(7), 2557–2571 (2019). https://doi.org/10.1007/s00261-019-01984-7
Castillo-Secilla, D., et al.: KnowSeq R-Bioc package: the automatic smart gene expression tool for retrieving relevant biological knowledge. Comput. Biol. Med. 133, 104387 (2021). https://doi.org/10.1016/j.compbiomed.2021.104387
Crosbie, E.J., Zwahlen, M., Kitchener, H.C., Egger, M., Renehan, A.G.: Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 19(12), 3119–3130 (2010). https://doi.org/10.1158/1055-9965.epi-10-0832
He, Z., et al.: The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma. BMC Cancer 22(1) (2022). https://doi.org/10.1186/s12885-022-09826-4
Kim, Y.W., et al.: Target-based molecular signature characteristics of cervical adenocarcinoma and squamous cell carcinoma. Int. J. Oncol. 43(2), 539–547 (2013). https://doi.org/10.3892/ijo.2013.1961
Martínez-Rodríguez, F., et al.: Understanding cervical cancer through proteomics. Cells 10(8), 1854 (2021). https://doi.org/10.3390/cells10081854
Okuda, T., et al.: Genetics of endometrial cancers. Obstet. Gynecol. Int. 2010, 1–8 (2010). https://doi.org/10.1155/2010/984013
Sung, H., et al.: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J. Clin. 71(3), 209–249 (2021). https://doi.org/10.3322/caac.21660
Wu, X., et al.: Identification of key genes and pathways in cervical cancer by bioinformatics analysis. Int. J. Med. Sci. 16(6), 800–812 (2019). https://doi.org/10.7150/ijms.34172
Acknowledgements
This work was funded by the Spanish Ministry of Sciences, Innovation and Universities under Project PID2021-128317OB-I00 and the projects from Junta de Andalucia P20-00163.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Almorox, L., Herrera, L.J., Ortuño, F., Rojas, I. (2023). Uterine Cervix and Corpus Cancers Characterization Through Gene Expression Analysis Using the KnowSeq Tool. In: Rojas, I., Valenzuela, O., Rojas Ruiz, F., Herrera, L.J., Ortuño, F. (eds) Bioinformatics and Biomedical Engineering. IWBBIO 2023. Lecture Notes in Computer Science(), vol 13920. Springer, Cham. https://doi.org/10.1007/978-3-031-34960-7_33
Download citation
DOI: https://doi.org/10.1007/978-3-031-34960-7_33
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-34959-1
Online ISBN: 978-3-031-34960-7
eBook Packages: Computer ScienceComputer Science (R0)